Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7P3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,913
Award facts
- Contract value 100% obligated
- $66,913.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $66,913 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes. This is a non-set-aside competitive award with an ultimate completion date of January 13, 2026, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
HEPLISAV-B is a recombinant hepatitis B vaccine indicated for prevention of infection caused by all known subtypes of hepatitis B virus. This delivery order reflects the ongoing pharmaceutical supply needs of the Defense Health Agency and military treatment facilities, demonstrating AmerisourceBergen's continued role as a critical supplier of vaccines and immunological products within the federal medical supply chain. The rapid completion timeline—with award and ultimate completion occurring within one day—is consistent with delivery order execution patterns under the large umbrella IDC vehicle.
Quick answers
Who was awarded contract SPE2DR26FV7P3?
SPE2DR26FV7P3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV7P3 worth?
The government has obligated $66,913 on SPE2DR26FV7P3.
Is contract SPE2DR26FV7P3 an order under another contract?
Yes. SPE2DR26FV7P3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7P3 competed?
The extent of competition for SPE2DR26FV7P3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award